María Eva Mingot‐Castellano

Instituto de Biomedicina de Sevilla — Spain

Medicine · Health Sciences

25h-index2.6kcitations179works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Platelet Disorders and Treatments(79), Hemophilia Treatment and Research(55), Blood groups and transfusion(47), Complement system in diseases(28), Coagulation, Bradykinin, Polyphosphates, and Angioedema(20)

Publications179 total

Clinical characteristics, treatment strategies, and response patterns in evans syndrome: Initial analysis from the spanish resti cohort
Blood·2025Open Access
A multicenter, randomized, open-label study of dexamethasone versus romiplostim plus dexamethasone as first line treatment in patients with newly diagnosed immune thrombocytopenia: Interim results of rodex study
Blood·2025Open Access
Comparative analysis of toxicity and efficacy of melphalan at doses of 140 mg/m2 VS. 200 mg/m2 as a conditioning regimen prior to autologous stem cell transplantation.
Blood·2025Open Access
Review of the management of patients with immune thrombotic thrombocytopenic purpura with persistently low adamts-13 activity - a challenge beyond rarity.
Blood·2025
Patient-reported outcomes of avatrombopag for chronic immune thrombocytopenia: Interim analysis of the Phase 4 adopt study
Blood·2025Open Access
Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain
Blood·2025Open Access
Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU
Revista Española de Cardiología (English Edition)·2025
Infectious complications in acquired haemophilia A: Insights from the Spanish Registry (AHASR)
Haematologica·2025Open Access
Abordaje del tratamiento antitrombótico durante el perioperatorio y el periprocedimiento: documento de consenso 2025 de SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT y AEU
Revista Española de Cardiología·2025
Correction: Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025
Intensive Care Medicine·2025Open Access
Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025
Intensive Care Medicine·2025· 5 cited
Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry
HemaSphere·2025· 2 citedOpen Access
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
EClinicalMedicine·2025· 22 citedOpen Access
Caplacizumab Added to Plasma Exchange and Immunosuppression Accelerates Recovery and Improves Survival in Immune-Mediated TTP: an International Real-World Study of the IWG-TTP (The Capla 1000+Project)
Hämostaseologie·2025
A phase 1/2 safety and efficacy study of TAK‐754 gene therapy: The challenge of achieving durable factor VIII expression in haemophilia A clinical trials
Haemophilia·2024· 8 citedOpen Access
HTA335 A Multi-Criteria Decision Analysis (MCDA) to Determine the Value of Recombinant ADAMTS3 Vs Standard of Care in Congenital Thrombotic Thrombocytopenic Purpura (cTTP) in Spain
Value in Health·2024
Use of Steroids in Subjects with ITP in Spain: Duration and Toxicity
Blood·2024
Avespa Study: Effectiveness and Safety of Avatrombopag in Immune Thrombocytopenia (ITP). a Real-World Study of the Spanish ITP Group (GEPTI)
Blood·2024
ADAMTS13 Activity Measurement Using a Chemiluminescence-Based Technique. Prospective Multicenter Comparative Study of the Spanish Apheresis Group (GEA)- Spanish Society of Hematology and Hemotherapy (SEHH)
Blood·2024
Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments
Blood·2024
page 1 of 9Next →

Frequent Co-authors

Cristina Pascual(13), María Román(11), Tomás José González‐López(9), Víctor Jiménez‐Yuste(8), Blanca Sánchez‐González(7), José Ramón González‐Porras(7), María Fernanda López Fernández(7), Faustino García‐Candel(7), Javier García‐Frade(6), David Valcárcel(6), Santiago Bonanad(6), Pascual Marco(6), Inmaculada Soto(6), Isidro Jarque(5), Carlos Aguilar(5), Johnny Mahlangu(5), Javier de la Rubia(5), Julio del Río-Garma(5), Reyes Jiménez‐Bárcenas(5), Ramiro Núñez(5)